R Qayyum, S Bolen, N Maruthur, L Feldman, … - Annals of Internal Medicine, 2008 - Am Coll Physicians Background: Evidence comparing premixed insulin analogues (a mixture of
rapid-acting and intermediate-acting insulin analogues) with other antidiabetic
agents is urgently required to guide appropriate therapy. Cited by 20 - Related articles - All 8 versions
CI Tîrgovişte, R Străchinariu, E Farcaşiu, Z … - Romanian journal of internal medicine= Revue …, 2003 - ncbi.nlm.nih.gov BACKGROUND: Humalog Mix 25 (Mix 25) is a premixed insulin mixture of 25% lispro
and 75% neutral protamine lispro. Insulin lispro is an analog of human insulin.
It is created when the amino acids at positions 28 and 29 of the B-chain of ... Cited by 6 - Related articles - All 2 versions
DE DeWitt, DC Dugdale - Primary Care: Clinics in Office Practice, 2003 - Elsevier More than 16 million Americans have diabetes, 95% of whom have type 2 diabetes
[1]. Most patients with diabetes are managed in an outpatient primary care
setting. Because all patients with type 1 diabetes require insulin and 90% ... Cited by 4 - Related articles - BL Direct - All 3 versions
- ►nih.gov - Free from Publisher RM Bergenstal, M Johnson, MA Powers, A … - Diabetes Care, 2008 - Am Diabetes Assoc RESEARCH AND DESIGN METHODS—This 24-week, multicenter, randomized, controlled
study compared two algorithms for adjusting mealtime (glulisine) insulin along
with a standard algorithm for adjusting background (glargine) insulin in ... Cited by 20 - Related articles - All 10 versions
AB King, DU Armstrong - Current Diabetes Reviews, 2005 - ingentaconnect.com Abstract: Basal bolus insulin dosing (BBD) may be defined as the physiological
replacement of basal and bolus insulin to achieve near normal glycemia without
hypoglycemia and loss of life quality. Normally, continuous and variable ... Cited by 5 - Related articles - BL Direct - All 2 versions
D Gordin, M Rönnback, C Forsblom, V … - Diabetes Research and Clinical Practice, 2008 - Elsevier AIMS: Evidence suggests that chronic hyperglycaemia predicts not only
microvascular disease but also macrovascular disease, however it is not known
whether it is the glucose variability per se or the total glucose exposure ... Cited by 6 - Related articles - All 11 versions
SD Wittlin - The Diabetes Educator, 2006 - tde.sagepub.com Type 2 diabetes represents a spectrum of metabolic abnormalities with both
insulin resistance and insulin deficiency (Table 1). Patients can present in a
variety of ways. The "classic" patient with type 2 diabetes is obese, ... Cited by 8 - Related articles - All 3 versions
AV Matveyenko, PC Butler - Diabetes Obes Metab, 2008 - interscience.wiley.com Regulation of blood glucose concentrations requires an adequate number of
β-cells that respond appropriately to blood glucose levels. β-Cell mass cannot
yet be measured in humans in vivo, necessitating autopsy studies, although ... Cited by 8 - Related articles - All 2 versions
A Rolla - The American Journal of Medicine, 2008 - Elsevier Human insulin preparations administered to patients with diabetes mellitus fail
to reproduce the normal physiologic pattern of insulin secretion. Modifications
have been made in the amino acid sequence of the insulin molecule with the ... Cited by 15 - Related articles - All 17 versions
